• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PLAMERE PLASMA PEN; LIGHT BASED OVER THE COUNTER WRINKLE REDUCTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PLAMERE PLASMA PEN; LIGHT BASED OVER THE COUNTER WRINKLE REDUCTION Back to Search Results
Medical Device Problem Code Inadequate or Insufficient Training (1643)
Health Effect - Clinical Code Scar Tissue (2060)
Date of Event 05/28/2021
Type of Reportable Event Serious Injury
Event or Problem Description
Severe facial scarring; i had a full face plasma pen treatment with plamere plasma pen that left me with hundreds of small atrophic scars on several areas of my face.The procedure is being done by non-medical technicians who have no skin care training.Fda safety report id# (b)(4).
 
Event or Problem Description
Additional information received for report number mw5109378 on 06/08/2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLAMERE PLASMA PEN
Common Device Name
LIGHT BASED OVER THE COUNTER WRINKLE REDUCTION
MDR Report Key14218771
Report NumberMW5109378
Device Sequence Number5838059
Product Code OHS
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial,Followup
Report Date (Section B) 04/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Other
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/26/2022
Supplement Report FDA Received Date06/08/2022
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age42 YR
Patient SexFemale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-